A compound of Formula I or Formula II and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula I or Formula II, and methods of treating conditions associated with the activity of p38 kinase.